John W. Childs - 15 Nov 2021 Form 4 Insider Report for Biohaven Pharmaceutical Holding Co Ltd.

Role
Director
Signature
/s/ Jim Engelhart, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
15 Nov 2021
Net transactions value
+$4,013,418
Form type
4
Filing time
17 Nov 2021, 18:03:51 UTC
Previous filing
10 Nov 2021
Next filing
29 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHVN Common Shares Options Exercise $129,625 +212,500 +8.3% $0.6100* 2,763,301 15 Nov 2021 Direct
transaction BHVN Common Shares Options Exercise $840,000 +150,000 +5.4% $5.60 2,913,301 15 Nov 2021 Direct
transaction BHVN Common Shares Options Exercise $350,233 +37,700 +1.3% $9.29 2,951,001 15 Nov 2021 Direct
transaction BHVN Common Shares Options Exercise $517,680 +18,000 +0.61% $28.76 2,969,001 15 Nov 2021 Direct
transaction BHVN Common Shares Options Exercise $1,111,680 +18,000 +0.61% $61.76* 2,987,001 15 Nov 2021 Direct
transaction BHVN Common Shares Options Exercise $216,400 +20,000 +0.67% $10.82 3,007,001 15 Nov 2021 Direct
transaction BHVN Common Shares Options Exercise $847,800 +18,000 +0.6% $47.10* 3,025,001 15 Nov 2021 Direct
holding BHVN Common Shares 10,000 15 Nov 2021 By John W Childs 2013 Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHVN Stock Option (Right to Buy) Options Exercise $0 -212,500 -100% $0.000000* 0 15 Nov 2021 Common Shares 212,500 $0.6100 Direct F1
transaction BHVN Stock Option (Right to Buy) Options Exercise $0 -150,000 -100% $0.000000* 0 15 Nov 2021 Common Shares 150,000 $5.60 Direct F2
transaction BHVN Stock Option (Right to Buy) Options Exercise $0 -37,700 -100% $0.000000* 0 15 Nov 2021 Common Shares 37,700 $9.29 Direct F3
transaction BHVN Stock Option (Right to Buy) Options Exercise $0 -18,000 -100% $0.000000* 0 15 Nov 2021 Common Shares 18,000 $28.76 Direct
transaction BHVN Stock Option (Right to Buy) Options Exercise $0 -18,000 -100% $0.000000* 0 15 Nov 2021 Common Shares 18,000 $61.76 Direct
transaction BHVN Stock Option (Right to Buy) Options Exercise $0 -20,000 -100% $0.000000* 0 15 Nov 2021 Common Shares 20,000 $10.82 Direct F4
transaction BHVN Stock Option (Right to Buy) Options Exercise $0 -18,000 -100% $0.000000* 0 15 Nov 2021 Common Shares 18,000 $47.10 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vested as to 25% of the shares on November 26, 2014, and the remainder vested in 3 equal installments on the first, second and third anniversaries of the grant date.
F2 The shares underlying this option vested as to 25% of the shares on October 23, 2015, and the remainder vested in 3 equal installments on the first, second and third anniversaries of the grant date.
F3 The shares underlying this option vested as to 25% of the shares on December 15, 2016, and the remainder vested in 3 equal installments on the first, second and third anniversaries of the grant date.
F4 The shares underlying this option vested as to 25% of the shares on April 6, 2017, and the remainder vested in 3 equal installments on the first, second and third anniversaries of the grant date.